Top Analyst Upgrades and Downgrades: AMR, Endo Health, T-Mobile, VIVUS and More

Jon C. Ogg

This week marks the last one of major earnings reports, and both the DJIA and S&P 500 Index have recently challenged new all-time highs. Investors and traders have to wonder which stocks to buy, which to sell and which to avoid. 24/7 Wall St. reviews dozens of Wall Street analyst research notes each morning with a keen eye on finding new ideas for our readers. These are this Wednesday's top analyst upgrades, downgrades and initiations seen from Wall Street research firms.

AMR Corp. (AAMRQ) was downgraded to Neutral from Overweight by J.P. Morgan.

Cardinal Health Inc. (CAH) was raised to Buy from Neutral and its price target was raised to $73 from $59 at Sterne Agee.

ALSO READ: 10 Brands That Will Disappear in 2014

Endo Health Solutions Inc. (ENDP) was raised to Neutral from Underweight at Piper Jaffray.

Halcon Resources Corp. (HK) was downgraded to Hold from Buy at Canaccord Genuity.

Pattern Energy Group Inc. (PEGI) was started as Buy with a $28 price target at Bank of America Merrill Lynch.

Pioneer Natural Resources Co. (PXD) was downgraded to Neutral from Buy at Sterne Agee.

Red Robin Gourmet Burgers Inc. (RRGB) was downgraded to Underperform from Neutral at Bank of America Merrill Lynch.

Ryanair Holdings PLC (RYAAY) was raised to Buy from Neutral at Nomura after the fresh sell-off.

Solazyme Inc. (SZYM) was downgraded to Neutral from Outperform at Credit Suisse.

T-Mobile US Inc. (TMUS) was raised to Buy from Hold at Canaccord Genuity.

Unilever PLC (UL) was downgraded to Neutral from Buy at Nomura.

United Technologies Corp. (UTX) was reiterated Buy and the price target was raised to $120 at Argus.

VIVUS Inc. (VVUS) was downgraded to Neutral from Buy at Bank of America Merrill Lynch.